Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial

Effects of cannabidiol in the treatment of patients with Parkinson's disease: An exploratory double-blind trial.

“Parkinson’s disease (PD) has a progressive course and is characterized by the degeneration of dopaminergic neurons.… the endocannabinoid system has emerged as a promising target.…Our findings point to a possible effect of CBD in improving quality of life measures in PD patients with no psychiatric comorbidities…”

http://www.ncbi.nlm.nih.gov/pubmed/25237116  (PubMed)

 


This Research and Resources page is sponsored by the Ohio Rights Group Education Fund.
Please support our charitable and educational work by making a generous tax deductible donation.